Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C055506 |
4-(diethylamino)benzaldehyde |
4-(diethylamino)benzaldehyde results in decreased expression of TWIST1 protein | decreases expression | 16316642
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of TWIST1 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TWIST1 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
TWIST1 protein results in decreased susceptibility to Arsenic | decreases response to substance | 19806464
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of TWIST1 mRNA | decreases expression | 18042831
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of TWIST1 mRNA | affects cotreatment|decreases expression | 17404688
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of TWIST1 gene | increases mutagenesis | 16724327
|
D005480 |
Flurbiprofen |
Flurbiprofen results in decreased expression of TWIST1 mRNA | decreases expression | 16949054
|
C041786 |
palm oil |
palm oil results in decreased expression of TWIST1 mRNA | decreases expression | 18042831
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of TWIST1 mRNA | affects cotreatment|decreases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in decreased expression of TWIST1 mRNA | decreases expression | 17404688
|
D013792 |
Thalidomide |
Thalidomide results in decreased expression of TWIST1 mRNA | decreases expression | 12242718 14713331
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of TWIST1 protein | increases expression | 16316642
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
4.71 | 8333272 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.71 | 18287403 |
MESH:D000168 |
Acrocephalosyndactylia |
marker/mechanism |
|
| 15923834 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.12 | 11473722 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.78 | 6695378 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Flurbiprofen |
5.17 | 10680582 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.39 | 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.70 | 15955085 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
4.42 | 16510725 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.89 | 16835338 16251483 18414634 12569548 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.03 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
8.00 | 9598899 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
8.00 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.29 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.37 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.31 | 12928151 19371607 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.53 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.72 | 16206674 16197459 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.98 | 14991843 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.51 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.40 | 15665606 15380490 15845082 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.39 | 18412241 16651633 16357521 16436596 15144691 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.98 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.98 | 16675129 12948864 17289903 18497071 17261762 17018787 19861407 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.98 | 16175315 17614352 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.98 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.74 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.62 | 16111702 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.65 | 15504454 17687452 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.33 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
9.08 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
9.08 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
9.08 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
9.08 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
9.08 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
4.90 | 18922899 17687452 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.90 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.18 | 18640142 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.52 | 19152805 17938729 15738583 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.41 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.15 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
7.26 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
7.26 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.16 | 17160924 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.74 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
4.97 | 18291259 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.33 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.71 | 9407595 |
MESH:D003092 |
Colitis |
|
Thalidomide |
10.36 | 16680017 |
MESH:D003092 |
Colitis |
|
Tretinoin |
10.36 | 17035595 |
MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
5.71 | 9301478 |
MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
6.48 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
3.10 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.10 | 9211117 16925845 9142499 10589399 9224671 8800419 9664655 17551590 9125849 14991402 |
OMIM:123100 |
CRANIOSYNOSTOSIS, TYPE 1 |
marker/mechanism |
|
| |
MESH:D003424 |
Crohn Disease |
|
Thalidomide |
4.21 | 16078585 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.51 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.63 | 17187935 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.53 | 18367378 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.16 | 18357618 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.64 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.91 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.65 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.65 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.87 | 16134523 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.66 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
3.35 | 19004024 17967931 19551842 18296743 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
9.30 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.30 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.73 | 6392382 |
MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
6.48 | 12701121 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
7.65 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.65 | 17312396 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
6.83 | 16357521 16651633 18412241 |
MESH:D005910 |
Glioma |
|
Thalidomide |
6.83 | 16327979 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.26 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.33 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.95 | 14991402 9664655 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.21 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.93 | 17088409 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.30 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.70 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.71 | 16778211 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.56 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.73 | 21332399 |
MESH:D006973 |
Hypertension |
|
Arsenic |
2.90 | 9931084 16076760 11953799 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.73 | 16093927 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.54 | 15869954 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
12.57 | 20412841 |
MESH:D007249 |
Inflammation |
|
Flurbiprofen |
12.57 | 11099482 |
MESH:D007249 |
Inflammation |
|
Progesterone |
12.57 | 15869954 |
MESH:D007249 |
Inflammation |
|
Thalidomide |
12.57 | 16134734 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.60 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.60 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.90 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.01 | 15992940 17551590 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.14 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.64 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
8.02 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
8.02 | 17379185 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
4.42 | 16514283 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.82 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.81 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
4.34 | 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.34 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.99 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.99 | 19642359 16891316 9834237 19075265 19035177 17361223 17712046 16935935 17107899 16766008 17339181 19029980 17368321 17301526 17217047 16140955 16788101 17294898 19225113 17649720 12679006 17506722 16823087 15748426 16331271 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
8.81 | 10473037 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
8.81 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
7.26 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
7.26 | 17174718 16943688 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.73 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
3.73 | 15465738 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.73 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.56 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
4.92 | 18177683 2125692 9163691 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
4.92 | 16368122 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.80 | 8603461 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.70 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
3.70 | 17976673 19168569 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
3.70 | 16271038 16019985 17703301 6695378 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
4.02 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.19 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.50 | 17203775 16891317 11807958 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
10.50 | 10838139 18041768 10767621 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
10.50 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.66 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.82 | 17453147 |
MESH:D008545 |
Melanoma |
|
Thalidomide |
3.78 | 16098027 12829675 17089043 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.78 | 16752155 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.16 | 17943659 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.56 | 16940565 |
MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
4.27 | 19112817 15920492 19112201 15867202 16445831 19372569 17168659 15744524 15939924 15741222 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
7.99 | 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.99 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
4.07 | 15371236 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.36 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
marker/mechanism |
|
| 19806464 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.46 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.54 | 16707424 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.89 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
17.33 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
17.33 | 16859833 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
17.33 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.66 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.66 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.57 | 16003739 17160924 16651423 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.49 | 17056641 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.31 | 18674790 20518802 19632207 20132043 11836018 17217161 21332399 16723640 18457598 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.16 | 17160924 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
15.34 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
15.34 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
15.34 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
15.34 | 16288038 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
15.34 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.99 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.50 | 15976015 |
MESH:D010291 |
Paresis |
|
Thalidomide |
6.48 | 9200351 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.30 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.14 | 6392382 15371236 16905509 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
4.29 | 17031469 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.99 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.19 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.19 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flurbiprofen |
2.19 | 17409433 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
2.19 | 16729912 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
9.67 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
9.67 | 16636307 |
MESH:D011536 |
Prurigo |
|
Thalidomide |
6.48 | 12755975 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.95 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.22 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.89 | 18045962 |
MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
6.09 | 16096327 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.77 | 6392382 17548696 18709164 15952646 16702368 17050553 19834688 17453740 16759981 17938729 16353154 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
6.07 | 19538983 16251483 17976673 17029826 15504454 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
6.07 | 16467112 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.43 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 19806464 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
4.28 | 15138204 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.31 | 15790496 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.11 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.86 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.89 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.29 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
2.85 | 15987713 17306315 19429237 19322015 18640142 11144890 17976673 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.78 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.78 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
12.76 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
12.76 | 15741222 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.18 | 16761959 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.83 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.07 | 16287080 |